<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>BACKGROUND: <z:chebi fb="6" ids="39025">High density lipoprotein</z:chebi> (<z:chebi fb="17" ids="39025">HDL</z:chebi>) cholesterol is inversely associated to atherosclerotic cardiovascular risk </plain></SENT>
<SENT sid="1" pm="."><plain>Disturbances in <z:chebi fb="4" ids="47775">HDL cholesterol</z:chebi> plasma levels are frequent in the Chilean population, however the pathophysiological mechanisms are unknown </plain></SENT>
<SENT sid="2" pm="."><plain>AIM: To evaluate the mechanisms involved in the hypo and hyper alfalipoproteinemias in Chilean subjects </plain></SENT>
<SENT sid="3" pm="."><plain>MATERIALS AND METHODS: Twenty three subjects with <z:e sem="disease" ids="C0342883" disease_type="Disease or Syndrome" abbrv="">hyperalphalipoproteinemia</z:e> and 12 with <z:e sem="disease" ids="C0473527" disease_type="Disease or Syndrome" abbrv="">hypoalphalipoproteinemia</z:e>, paired with control subjects (col-<z:chebi fb="17" ids="39025">HDL</z:chebi> between 35 and 55 mg/dl) were studied </plain></SENT>
<SENT sid="4" pm="."><plain>We measured plasma <z:chebi fb="23" ids="18059">lipids</z:chebi>, subfractions and sizing of <z:chebi fb="17" ids="39025">HDL</z:chebi> particles and enzymatic activity of cholesteryl <z:chebi fb="21" ids="35701">ester</z:chebi> transfer protein (CETP), lecithtin: cholesterol acyltransferase (LCAT), <z:chebi fb="1" ids="6495">lipoprotein</z:chebi> lipase (LPL) and hepatic lipase (LH) </plain></SENT>
<SENT sid="5" pm="."><plain>RESULTS: Subjects with <z:e sem="disease" ids="C0342883" disease_type="Disease or Syndrome" abbrv="">hyperalphalipoproteinemia</z:e> showed significantly higher levels of total <z:chebi fb="4" ids="47775">HDL-cholesterol</z:chebi> (70 +/- 2 vs 44 +/- 1 mg/dl), <z:chebi fb="17" ids="39025">HDL</z:chebi> 2 (30 +/- 3 vs 5 +/- 1 mg/dl), Apo A I (175 +/- 3 vs 146 +/- 4 mg/dl), lower <z:e sem="disease" ids="C0019829" disease_type="Neoplastic Process" abbrv="hd">HL</z:e> activity (23.7 +/- 0.8 vs 32.4 +/- 1.8 mmol/h/l) and <z:chebi fb="17" ids="39025">HDL</z:chebi> particles of greater size, compared to their controls </plain></SENT>
<SENT sid="6" pm="."><plain>Subjects with <z:e sem="disease" ids="C0473527" disease_type="Disease or Syndrome" abbrv="">hypoalphalipoproteinemia</z:e>, showed significantly lower levels of total <z:chebi fb="4" ids="47775">HDL-cholesterol</z:chebi> (26 +/- 1 vs 48 +/- 2 mg/dl), <z:chebi fb="17" ids="39025">HDL</z:chebi> 3 (21 +/- 1 vs 40 +/- 2 mg/dl), Apo A I (107 +/- 5 vs 145 +/- 7 mg/dl), lower LCAT activity (18.6 +/- 1.9 vs 26.2 +/- 1.6 nmol/h/ml) and smaller <z:chebi fb="17" ids="39025">HDL</z:chebi> particles, compared to their controls </plain></SENT>
<SENT sid="7" pm="."><plain>CONCLUSION: Changes in hepatic lipase and lecithin cholesterol acyltransferase activities may explain the hyper and <z:e sem="disease" ids="C0473527" disease_type="Disease or Syndrome" abbrv="">hypo alphalipoproteinemia</z:e> respectively, in Chilean subjects </plain></SENT>
</text></document>